Ranbaxy Laboratories has dipped nearly 3% to Rs 360 on the BSE, on reports that the company has recalled some batches of its generic version of cholesterol-lowering Lipitor drug in the US after a dosage mix-up was detected.
According to the report, the company voluntarily recalled 64,626 bottles containing atorvastatin calcium (generic Lipitor) tablets after a pharmacist found a 20-mg tablet in a sealed bottle marked for 10-mg tablets, an enforcement report posted on the FDA’s website said.
The stock opened at Rs 369 and touched a low of Rs 358 on the BSE. A combined around 100,000 shares changed hands on the counter in early morning deals on the BSE and NSE.
According to the report, the company voluntarily recalled 64,626 bottles containing atorvastatin calcium (generic Lipitor) tablets after a pharmacist found a 20-mg tablet in a sealed bottle marked for 10-mg tablets, an enforcement report posted on the FDA’s website said.
The stock opened at Rs 369 and touched a low of Rs 358 on the BSE. A combined around 100,000 shares changed hands on the counter in early morning deals on the BSE and NSE.
